Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Ampoule 10 x 10 ml |
|
Dosage
4ml/kg body weight/day to preterm and low birth weight infants up to 2.5 kg body weight , and 10ml/day for all infants and children weighing more than 2.5kg up to 11 years of age.
Indications
VITALIPID N INFANT is indicated in infants and children up to 11 years of age as a supplement in intravenous nutrition to meet the daily requirements of the fat-solublevitaminsA,D2,EandK1.
Contra-Indications
Hypersensetivity to egg ,soy-orpeanut-protein or to any of the active substances or excipients.
Special Precautions
This medical product contains soya-bean oil and egg phospholipids,which may rarely cause allergic reactions. Cross allergic reactions have been observed betweensoya-beanandpeanut.
This product must not be given undiluted.
Side Effects
No adverse effects related to this product have been reported.
Drug interactions
The presence of trace elements may cause some degradation of vitamin A. Retinol(vitaminA)may be broken down by exposure to ultravioletlight. Vitamin K1 interacts with anticoagulants of the coumarin type.
Pregnancy and Lactation
Not applicable.
Overdose
Overdoses of fat-soluble vitamins may lead to toxicity syndromes, but there is no evidence of any toxicity at the dosages recommended.
No adverse effects of a single overdose of fat-soluble vitamins should occur. No specific treatment is needed.
After prolonged infusion of an overdose of Vitamin D, elevated serum concentrations of Vitamin D metabolites may occur. This may cause osteopenia. Rapid infusion of Vitamin K1 in colloid water solution may provoke flushing, bronchospasm, tachycardia and hypotension. This has not been reported after infusions of VITALIPID N INFANT.
